Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_06-cv-01063/USCOURTS-caed-2_06-cv-01063-6/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1441 Petition for Removal- Product Liability

---

ORDER TO SEAL EXHS. TO PREEMPTION SUMM JUDGMT. MOT. 2:06-CV-01063-FCD-DAD 

- 1 - 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

UNITED STATES DISTRICT COURT 

EASTERN DISTRICT OF CALIFORNIA 

SACRAMENTO DIVISION 

TERRI S. O’NEAL, individually and as 

successor-in-interest to the Estate of 

BENJAMIN L. BRATT; BARRY M. 

BRATT, individually, 

 Plaintiffs, 

 vs. 

SMITHKLINE BEECHAM 

CORPORATION d/b/a 

GLAXOSMITHKLINE, a Pennsylvania 

Corporation; McKESSON 

CORPORATION, a California 

Corporation; and DOES 1-50. 

 Defendants. 

 

 Case No.: 2:06-CV-01063-FCD-DAD 

ORDER GRANTING 

DEFENDANT SMITHKLINE 

BEECHAM CORPORATION d/b/a 

GLAXOSMITHKLINE’S EX PARTE 

APPLICATION TO FILE CERTAIN 

EXHIBITS TO ITS MOTION FOR 

SUMMARY JUDGMENT ON FEDERAL 

PREEMPTION GROUNDS UNDER SEAL 

 Defendant SmithKline Beecham Corporation d/b/a GlaxoSmithKline’s (“GSK”) Ex Parte 

Application to File Certain Exhibits to its Motion for Summary Judgment on Federal Preemption 

Grounds Under Seal is GRANTED. GSK may file paragraphs 22-23, 30-34, 42, 49, 57-58, 62-63, 67, 

and 70-74 of the Declaration of Barbara E. Arning, M.D., under Seal. GSK may also file the following 

exhibits to Dr. Arning’s declaration under seal: Exhibits 1-2, 7-16, 21, 28, 33-34, 36-37, 39 and 42-45. 

IT IS SO ORDERED. 

Dated: October 17, 2007 

Case 2:06-cv-01063-FCD-DAD Document 127 Filed 10/17/07 Page 1 of 1